Brigit Biofarmaka Teknologi Tbk. vs Bersama Zatta Jaya Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Bersama Zatta Jaya Tbk. trades at Rp68 (market cap 577.73B, 37.25M 24h volume). The key difference: Bersama Zatta Jaya Tbk. is far larger — about 3.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bersama Zatta Jaya Tbk. is more actively traded (37.25M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | ZATA | |
|---|---|---|
Market Cap | 164.65B | 577.73B |
Volume | 62.5K | 37.25M |
Lot | 625 | 372.46K |
Turnover | 15.03M | 2.53B |
Average Price | 240.55 | 67.87 |
Value | 15.03M | 2.53B |
Indicative Equilibrium Price | 238 | 68 |
Indicative Equilibrium Volume | 100 | 9.2K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Bersama Zatta Jaya Tbk (the Company) was established based on notarial deed No. 39 datedApril 16, 2012 of Ermilla Ananta Cahyani,S.H., notary in Bandung. The company started its commercial activities since 2012.
Read more on ZATA →